US but was banned from sale in the UK market. The drug was outlawed in the UK, and its UK supplier had to decide if the substantial inventory could be "dumped" on the US market to recoup losses. In the case of Halcion the US had deemed the product was in need of stronger warning labels but was still safe for consumers, while the UK regulatory agency had deemed it unsafe. In this situation product dumping was probably the most logical solution, as the product was deemed safe by the FDA in the US as a viable therapeutic product. In the case of the
             ...